Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Porter

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Tissue Engineering|May 24, 2007
Facilitated endogenous repair: making tissue engineering simple, practical, and economicalChris H Evans, Glyn D Palmer, Arnulf Pascher, et al.
Mayo Clinic Proceedings|January 6, 2026
Association of Body Fatness With Hypertension, Dyslipidemia, and Myocardial Infarction in a Multinational Pooled CohortVivek Kumar Prasad, Chibueze Ogbonnaya, Hannah Oh, et al.
Haematologica|January 25, 2024
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignanciesLinlin Xu, Mazyar Shadman, Ian W Flinn, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomasAmy Y Huang, Kelly P Burke, Ryan Porter, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Tissue Engineering|May 24, 2007
Facilitated endogenous repair: making tissue engineering simple, practical, and economicalChris H Evans, Glyn D Palmer, Arnulf Pascher, et al.
Mayo Clinic Proceedings|January 6, 2026
Association of Body Fatness With Hypertension, Dyslipidemia, and Myocardial Infarction in a Multinational Pooled CohortVivek Kumar Prasad, Chibueze Ogbonnaya, Hannah Oh, et al.
Haematologica|January 25, 2024
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignanciesLinlin Xu, Mazyar Shadman, Ian W Flinn, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomasAmy Y Huang, Kelly P Burke, Ryan Porter, et al.
Pageof 2